Supply of Lisdexamfetamine 30 MG Capsules (90 Count Bottle)

This contract involves the manufacture and supply of Lisdexamfetamine capsules, each containing 30 mg of the active ingredient and packaged in 90-count bottles. The products must comply with FDA regulations and adhere to Trade Agreements Act (TAA) requirements. Additionally, the capsules are required to have bar-coded labeling for accurate identification and tracking, as well as compatibility with automated dispensing systems to ensure seamless integration within existing medical distribution infrastructures. The contract is issued by the Defense Logistics Agency Troop Support under the Department of Defense, with a solicitation date of June 2, 2026, and a response deadline of July 2, 2026. It falls under the NAICS code 325412, which relates to pharmaceutical manufacturing. Specific details such as location and point of contact are not provided, and the contract is categorized as a subcontract opportunity. This engagement highlights a focus on supplying critical pharmaceutical products to support healthcare needs within military operations or associated agencies.